AE-34-SK19_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, 3-{[(5-Chloro-3-methyl-1-benzothien-2-yl)sulfonyl]amino}benzoic acid, 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3 (PFKFB3) Inhibitors targeting PFKFB3, PFKFB4 (Novartis, 56941306)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/56941306
Similar Terms
Downloads & Tools

Genes

9 genes differentially expressed following the AE-34-SK19_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
RNASEK ribonuclease, RNase K 0.46749
PPM1F protein phosphatase, Mg2+/Mn2+ dependent, 1F 0.238749

decreased expression

Symbol Name Standardized Value
PLK2 polo-like kinase 2 -0.326905
PRKAG1 protein kinase, AMP-activated, gamma 1 non-catalytic subunit -0.318996
ZNF276 zinc finger protein 276 -0.28701
MMP9 matrix metallopeptidase 9 -0.259665
RGS10 regulator of G-protein signaling 10 -0.258405
UBE2D3 ubiquitin-conjugating enzyme E2D 3 -0.254074
BMPR2 bone morphogenetic protein receptor, type II (serine/threonine kinase) -0.207731